Koeller, Diane R.; Walker, McKenzie; Unal, Busra; Chittenden, Anu; Levine, Alison Schwartz; Hayes, Connor P.; Oramasionwu, Paul C.; Manam, Monica D.; Buehler, Ryan M.; Gomy, Israel 
; Silva Junior, Wilson Araújo da ; Lerner-Ellis, Jordan; Casalino, Selina; Mahajan, Radhika; Watkins, Nicholas; Agaoglu, Nihat Bugra; Manning, Danielle K.; Barletta, Justine A.; Hornick, Jason L.; Lindeman, Neal I.; Sholl, Lynette M.; Rana, Huma Q.; Garber, Judy E.; Ghazani, Arezou A.
Source: Cancers. Unidade: FMRP
Subjects: DOENÇAS HEREDITÁRIAS, NEOPLASIAS, GENÉTICA APLICADA, ONCOLOGIA, DIAGNÓSTICO DIFERENCIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOELLER, Diane R. et al. Advancing the landscape of clinical actionability in Von Hippel–Lindau syndrome: an evidence-based framework from the INT2GRATE oncology consortium. Cancers, v. 17, n. 13, p. 1-23, 2025Tradução . . Disponível em: https://doi.org/10.3390/cancers17132173. Acesso em: 25 abr. 2026.APA
Koeller, D. R., Walker, M. K., Unal, B., Chittenden, A., Levine, A. S., Hayes, C. P., et al. (2025). Advancing the landscape of clinical actionability in Von Hippel–Lindau syndrome: an evidence-based framework from the INT2GRATE oncology consortium. Cancers, 17( 13), 1-23. doi:10.3390/cancers17132173NLM
Koeller DR, Walker MK, Unal B, Chittenden A, Levine AS, Hayes CP, Oramasionwu PC, Manam MD, Buehler RM, Gomy I, Silva Junior WA da, Lerner-Ellis J, Casalino S, Mahajan R, Watkins N, Agaoglu NB, Manning DK, Barletta JA, Hornick JL, Lindeman NI, Sholl LM, Rana HQ, Garber JE, Ghazani AA. Advancing the landscape of clinical actionability in Von Hippel–Lindau syndrome: an evidence-based framework from the INT2GRATE oncology consortium [Internet]. Cancers. 2025 ; 17( 13): 1-23.[citado 2026 abr. 25 ] Available from: https://doi.org/10.3390/cancers17132173Vancouver
Koeller DR, Walker MK, Unal B, Chittenden A, Levine AS, Hayes CP, Oramasionwu PC, Manam MD, Buehler RM, Gomy I, Silva Junior WA da, Lerner-Ellis J, Casalino S, Mahajan R, Watkins N, Agaoglu NB, Manning DK, Barletta JA, Hornick JL, Lindeman NI, Sholl LM, Rana HQ, Garber JE, Ghazani AA. Advancing the landscape of clinical actionability in Von Hippel–Lindau syndrome: an evidence-based framework from the INT2GRATE oncology consortium [Internet]. Cancers. 2025 ; 17( 13): 1-23.[citado 2026 abr. 25 ] Available from: https://doi.org/10.3390/cancers17132173
